Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage IIIC ovarian Carcinoma

Cancer

Volumn 92, Issue 10, 2001, Pages 2585-2591

  Kuhn, Walther ^a,b,c,d   Rutke, Stefan ^a   Spaan̈the, Kerstin ^a   Schmalfeldt, Barbara ^a,c,d   Florack, Gerd ^a,d   Vonhundelshausen, Burkhardt ^c,d   Pachyn, Dmytro ^a   Ulm, Kurt ^a,b   Graeff, Henner ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Ascites; Neoadjuvant chemotherapy; Prognosis of ovarian carcinoma; Prognostic factors

Indexed keywords

PLATINUM; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; ASCITES; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GERMANY; HUMAN; MORBIDITY; MORTALITY; OVARY CARCINOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0035889879     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011115)92:10<2585::aid-cncr1611>3.0.co;2-%23     Document Type: Article

References (22)

1. Primary cytoreductive surgery for epithelial ovarian cancer
2. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity
3. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer
4. Entwicklungen in der therapie des fortgeschrittenen ovarialkarzinoms FIGO III
5. Primary cytoreductive surgery with rectosigmoid colon resection for patients with advanced epithelial ovarian carcinoma
6. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
7. The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV
8. Disease-adapted relapse therapy for ovarian cancer: Results of a prospective study
9. Ovarial cancer: Best timing and applications of debulking surgery
10. Neoadjuvant chemotherapy for advanced ovarian cancer
11. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
12. FIGO stages - 1998 revision
13. Sekundäre debulking-operation beim ovarialcarcinom
14. Nonparametric estimation from incomplete observations
15. Evaluation of survival data and two new rank order statistics arising in its consideration
16. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
17. Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction
18. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): Improved treatment for gastric adenocarcinoma
19. Interval debulking surgery: An alternative for primary surgical debulking?
20. Advanced ovarian cancer: Analysis of factors influencing resectability at initial surgery
21. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
22. The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma